Compare IDYA & TNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDYA | TNK |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.9B |
| IPO Year | 2019 | 2007 |
| Metric | IDYA | TNK |
|---|---|---|
| Price | $27.99 | $80.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 2 |
| Target Price | $52.86 | ★ $80.00 |
| AVG Volume (30 Days) | ★ 1.4M | 406.1K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 2.55% |
| EPS Growth | ★ 61.90 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $218,710,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $201.05 | N/A |
| P/E Ratio | ★ N/A | $8.05 |
| Revenue Growth | ★ 3024.43 | N/A |
| 52 Week Low | $17.17 | $41.05 |
| 52 Week High | $39.28 | $83.99 |
| Indicator | IDYA | TNK |
|---|---|---|
| Relative Strength Index (RSI) | 36.30 | 57.30 |
| Support Level | $26.05 | $71.94 |
| Resistance Level | $28.05 | $80.97 |
| Average True Range (ATR) | 1.15 | 2.67 |
| MACD | -0.12 | 0.20 |
| Stochastic Oscillator | 7.68 | 67.00 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Teekay Tankers Ltd is a provider of marine services to the international oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.